CERN Supported Research Uses New Approach to Calculate Drug Doses for Ependymoma Treatment

— Categories: CERN Research Articles     Posted on May 10, 2016

St. Jude Children’s Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a phase I clinical trial of a chemotherapy, 5-FU, for ependymoma treatment.

The research marked the first time the approach has been used to calculate drug doses for a clinical trial in pediatric brain tumor patients. Supported by the CERN Foundation.

To read the EurekAlert Article, click here.

Stay Informed with the CERN Newsletter

The CERN Foundation is committed to informing you with the latest ependymoma news and research. Join our mailing list for monthly updates.